New Conference to Tackle Cancer Treatment-Related Heart Issues
The ESC’s Cardio-Oncology 2025 conference will focus on addressing the growing need for integrated cardiovascular care in cancer treatment.
Read MoreThe ESC’s Cardio-Oncology 2025 conference will focus on addressing the growing need for integrated cardiovascular care in cancer treatment.
Read MoreThe FDA has cleared a portable ECG device that allows patients to capture a 30-second heart recording at home when symptoms occur, with the data sent to a physician for review and next steps.
Read MoreThe FDA has expanded the indications for Johnson & Johnson MedTech’s Impella CP and Impella 5.5 with SmartAssist heart pumps, granting premarket approval for use in specific pediatric patients with symptomatic acute decompensated heart failure and cardiogenic shock.
Read MoreA new gene therapy restored heart function and boosted survival in animals with heart failure. Researchers are now preparing it for human trials.
Read MoreThe pulsed field ablation technology for ventricular tachycardia has been granted FDA Breakthrough Device Designation and accepted into the TAP pilot program.
Read More